Who is ArchiMed?
ArchiMed was established in March 2014 by Denis Ribon and Vincent Guillaumot and is headquartered in Lyon with a focus on healthcare What does ArchiMed do? ArchiMed was established in March 2014 by Denis Ribon and Vincent Guillaumot and is headquartered in Lyon. Observing trends in the US, Ribon and Guillaumot left 3i / Cerba to start ArchiMed with the specific objective of becoming the leading healthcare specialist in Europe. The team has grown substantially over the past few years and now consists of >70 investment professionals as well as a “MedTalent Network” of >250 healthcare executives attempting to build a “one-stop shop for small and mid-cap healthcare private equity”. Some companies ArchiMed has invested in Polyplus NAMSA Carso Why do we back ArchiMed? “ArchiMed offers the opportunity to invest in a leading European dedicated healthcare specialist that has unparalleled operational expertise, particularly in the small and mid-cap market. Over the past few years of tracking ArchiMed, we have seen them evolve through strong hires and interesting deal execution. This expertise has been confirmed through abrdn's experience of working on the Polyplus transaction as well as other co-investment opportunities.” – Alistair Watson, Senior Investment Director, abrdn.
Western Europe and North America
Dedicated healthcare specialist. 6 target sub-sectors: MedTech, Biopharma, Life Sciences, Diagnostics, Consumer Health and Healthcare IT
Target Company Size
EV Range - €50 - 1bn
Recognised healthcare sector specialist with combined PE and extensive operational experience. Heavy buy-and-build focus